FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W236135089> ?p ?o ?g. }

• W236135089 endingPage "20" @default.
• W236135089 startingPage "513" @default.
• W236135089 abstract "The goals of this investigation were to compare the efficacy of three protective agents against cisplatin-induced elevation of auditory brainstem response (ABR) thresholds and to examine whether these protective agents prevent cisplatin-induced alterations of the antioxidant defense system in the cochlea of the rat.Cisplatin is an ototoxic antitumor agent. Previous animal studies have shown that cisplatin administration causes an elevation of ABR thresholds. These auditory changes are accompanied by alterations in the concentration of glutathione and the antioxidant enzymes in the cochlea. The authors' previous work has indicated that the protective agent diethyldithiocarbamate (DDTC) prevents decrease in glutathione (GSH), alteration of antioxidant enzyme activity, and disruption of cochlear function with cisplatin administration.Wistar rats were sedated and underwent pretreatment ABR testing using clicks and tone burst stimuli at 8, 16, and 32 kHz. Control rats received saline by intraperitoneal (i.p.) injection. Positive control rats were administered cisplatin 16 mg/kg i.p. Three groups of rats received protective agents in combination with cisplatin. The DDTC-protected rats were given 600 mg/kg of DDTC subcutaneously 1 hour after cisplatin. Animals protected by 4-methylthiobenzoic acid (MTBA) were given 250 mg/kg of this agent i.p. 30 minutes before cisplatin. Animals protected with ebselen were given 16 mg/kg i.p. one hour before cisplatin. The ABR thresholds were recorded 72 hours after cisplatin administration in all groups. Cochleas were removed, and extracts of the tissues were analyzed for GSH, activities of antioxidant enzymes (superoxide dismutase [SOD], catalase, glutathione peroxidase, and glutathione reductase) and malondialdehyde (MDA) (as an index of lipid peroxidation).Cisplatin-treated rats had significant ABR threshold shifts, ranging from 27 to 40 dB. Rats administered each of the three protective agents in combination with cisplatin had ABR threshold shifts of <10 dB. The cochleae of rats administered cisplatin alone had nearly a 50% depletion of glutathione and about a 50% reduction in the activities of SOD, glutathione peroxidase, and glutathione reductase, while catalase activity was reduced to 70% of control values. These changes were accompanied by a reciprocal elevation of MDA of 165%. These changes, namely, the depletion of GSH and antioxidant enzyme activity and the elevation of MDA in the cochlea, were largely attenuated by the administration of the protective agents tested.These findings suggest that cisplatin ototoxicity is related to lipid peroxidation and that the use of protective agents prevents hearing loss and lipid peroxidation by sparing the antioxidant system in the cochlea. These results suggest the possibility that the clinical use of protective agents could effectively reduce or prevent damage to the inner ear of patients receiving cisplatin chemotherapy, provided that the antitumor effect is not altered." @default.
• W236135089 created "2016-06-24" @default.
• W236135089 creator A5019319224 @default.
• W236135089 creator A5051591622 @default.
• W236135089 creator A5052036878 @default.
• W236135089 creator A5067591674 @default.
• W236135089 creator A5071609521 @default.
• W236135089 date "2000-07-01" @default.
• W236135089 modified "2023-10-11" @default.
• W236135089 title "Effect of protective agents against cisplatin ototoxicity." @default.
• W236135089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10912697" @default.
• W236135089 hasPublicationYear "2000" @default.
• W236135089 type Work @default.
• W236135089 sameAs 236135089 @default.
• W236135089 citedByCount "66" @default.
• W236135089 countsByYear W2361350892013 @default.
• W236135089 countsByYear W2361350892014 @default.
• W236135089 countsByYear W2361350892015 @default.
• W236135089 countsByYear W2361350892016 @default.
• W236135089 countsByYear W2361350892017 @default.
• W236135089 countsByYear W2361350892018 @default.
• W236135089 countsByYear W2361350892019 @default.
• W236135089 countsByYear W2361350892020 @default.
• W236135089 countsByYear W2361350892021 @default.
• W236135089 countsByYear W2361350892022 @default.
• W236135089 countsByYear W2361350892023 @default.
• W236135089 crossrefType "journal-article" @default.
• W236135089 hasAuthorship W236135089A5019319224 @default.
• W236135089 hasAuthorship W236135089A5051591622 @default.
• W236135089 hasAuthorship W236135089A5052036878 @default.
• W236135089 hasAuthorship W236135089A5067591674 @default.
• W236135089 hasAuthorship W236135089A5071609521 @default.
• W236135089 hasConcept C105702510 @default.
• W236135089 hasConcept C126322002 @default.
• W236135089 hasConcept C134018914 @default.
• W236135089 hasConcept C181199279 @default.
• W236135089 hasConcept C185592680 @default.
• W236135089 hasConcept C2775838275 @default.
• W236135089 hasConcept C2776151105 @default.
• W236135089 hasConcept C2776694085 @default.
• W236135089 hasConcept C2777397205 @default.
• W236135089 hasConcept C2778004101 @default.
• W236135089 hasConcept C2778239845 @default.
• W236135089 hasConcept C2778534666 @default.
• W236135089 hasConcept C2778760513 @default.
• W236135089 hasConcept C2779138974 @default.
• W236135089 hasConcept C2780130748 @default.
• W236135089 hasConcept C29730261 @default.
• W236135089 hasConcept C42219234 @default.
• W236135089 hasConcept C538909803 @default.
• W236135089 hasConcept C55493867 @default.
• W236135089 hasConcept C71924100 @default.
• W236135089 hasConcept C98274493 @default.
• W236135089 hasConceptScore W236135089C105702510 @default.
• W236135089 hasConceptScore W236135089C126322002 @default.
• W236135089 hasConceptScore W236135089C134018914 @default.
• W236135089 hasConceptScore W236135089C181199279 @default.
• W236135089 hasConceptScore W236135089C185592680 @default.
• W236135089 hasConceptScore W236135089C2775838275 @default.
• W236135089 hasConceptScore W236135089C2776151105 @default.
• W236135089 hasConceptScore W236135089C2776694085 @default.
• W236135089 hasConceptScore W236135089C2777397205 @default.
• W236135089 hasConceptScore W236135089C2778004101 @default.
• W236135089 hasConceptScore W236135089C2778239845 @default.
• W236135089 hasConceptScore W236135089C2778534666 @default.
• W236135089 hasConceptScore W236135089C2778760513 @default.
• W236135089 hasConceptScore W236135089C2779138974 @default.
• W236135089 hasConceptScore W236135089C2780130748 @default.
• W236135089 hasConceptScore W236135089C29730261 @default.
• W236135089 hasConceptScore W236135089C42219234 @default.
• W236135089 hasConceptScore W236135089C538909803 @default.
• W236135089 hasConceptScore W236135089C55493867 @default.
• W236135089 hasConceptScore W236135089C71924100 @default.
• W236135089 hasConceptScore W236135089C98274493 @default.
• W236135089 hasIssue "4" @default.
• W236135089 hasLocation W2361350891 @default.
• W236135089 hasOpenAccess W236135089 @default.
• W236135089 hasPrimaryLocation W2361350891 @default.
• W236135089 hasRelatedWork W1994790143 @default.
• W236135089 hasRelatedWork W2003937881 @default.
• W236135089 hasRelatedWork W2101006602 @default.
• W236135089 hasRelatedWork W2316107449 @default.
• W236135089 hasRelatedWork W2328645350 @default.
• W236135089 hasRelatedWork W2350202129 @default.
• W236135089 hasRelatedWork W236135089 @default.
• W236135089 hasRelatedWork W2530174344 @default.
• W236135089 hasRelatedWork W2588963375 @default.
• W236135089 hasRelatedWork W2941061534 @default.
• W236135089 hasVolume "21" @default.
• W236135089 isParatext "false" @default.
• W236135089 isRetracted "false" @default.
• W236135089 magId "236135089" @default.
• W236135089 workType "article" @default.